Home > Journals > Indian Journal of Genetics and Molecular Research

Indian Journal of Genetics and Molecular Research

Submit your article Read this Journals View all journals
Rekha

Editor-in-Chief

Dr. Rekha Chaubey

  • Address : Scientist, Biochemistry, All India Institute of Medical Sciences, India
  • E-Mail : drrekhacgupta@gmail.com

Research Interests :


Introduction


NADr Rekha Chaubey, MSc ,PhD, MBA (Hospital Administration) is presently working as a Research Scientist, in the Department of Pathology , AIIMS, New Delhi . She has completed her PhD from AIIMS, New Delhi from the Department of Hematology. She has published numerous papers on medical topics especially on Hematological malignancies, including tuberculosis, Myelodysplastic Syndromes, Chronic Myeloid Leukemias, Myeloproliferative disorders, Acute leukemias and other bone marrow failure diseases. She has She has received several national and international awards for her research work including Geeta Mittal Gold Medal for the Best Research (PhD) in basic sciences by AIIMS, New Delhi. She is the member of many scientific societies and reviewer and editorial member of several journals. Her research focuses on the molecular diagnostics and  molecular aspects of cancers including genetic mutations and their treatment outcomes.


AFFILIATION


Scientist

Biochemistry

All India Institute of Medical Sciences

Ansari Nagar

New Delhi

India

110029

Email : drrekhacgupta@gmail.com


RESEARCH IDS



RESEARCH INTERESTS


# Area
1. Cytogenetics,
2. Epigenetics
3. Genetics
4. Laboratory Management
5. Molecular Diagnostics
6. Molecular Hematology
7. Telomerase dynamics

PAPERS PUBLISHED


# Article Title Year
1. Role of molecular mutations, telomerase and promoter methylation status of the TSGs (p15INK4b, SOCS-1, calcitonin and FHIT) in disease severity, progression and survival in a series of 100 MDS patients: A study from India (Under review APJCP). NA
2. Distribution of common BCR-ABL fusion transcripts and their impact on treatment response in Imatinib treated CML patients: A study from India (2019).Indian J Pathol Microbiol. 62(2):256-260. 2019
3. Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemiachronic phase patients on imatinib (2018). South Asian J Cancer.;7(4):258-262. 2018
4. Reversal of Glanzmann thrombasthenia platelet phenotype after imatinib treatment in a pediatric chronic myeloid leukemia patient.Platelets. Mar;29(2):203-206. 2018
5. Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR–ABL1: A report of three cases from India.(2017) Annals of Diagnositc Pathology ; 27:24- 27. 2017
6. NPM1 and FLT3 mutations in AML with normal karyotype: Indian perspective.(2017)( Indian J Pathol Microbiol.;60(3):355- 359.) 2017
7. Does Indian MDS has biology different from West? (2015). Asian Pac J Cancer Prev. 2016;17(4):2341-2342). 2016
8. Influence of MDR1 gene polymorphism (C1236T) in response to Imatinib Mesylate in Chronic Myeloid Leukemia patients. Natl Med J India Nov-Dec;28(6):272-5. 2015
9. Prognostic relevance of aberrant SOCS-1 gene promoter methylation in MDS patients. (2014) International Journal of laboratory Hematology, Aug (13). 2014
10. MTHFR gene polymorphisms and the risk of acute lymphoblastic leukemia in adults and children : A case control study in India (2014). Indian J Hematol (Volume 30, Issue 4, pp 219-225). 2014
11. Molecular characterization of Indian patients with myelodysplastic syndromes.Leukemia Research 37 S1 (2013) S1–S117. 2013
12. Role of JAK2 mutation in patients with Splanchnic Venousthrombosis: A pilot study from India. (Indian Journal of Medical Research; 135,March : 429-431). 2012
13. Cytogenetic Profile of Indian patients with de novo Myelodysplastic Syndromes – AIIMS experience (Indian Journal of Medical Research 134, October: 452-457). 2011
14. Trisomy 9 in a patient with Acute Myelogenous Leukaemia FAB type M2 – a rare occurrence. Indian Journal of Hematology and blood transfusion (Vol. 26, No.3, Sep. Page -103-105). 2010
15. Haematological and molecular profile of acute myelogenous leukaemia in northern India. Indian Journal of Medical Research, 129:256-261. 2009
16. Childhood CML in India: b2a2 transcript is more common than b3a2(2006). Cancer Genetics and cytogenetics: Aug 169 (1) : 76-77. 2008
17. Impact of FLT3 Internal tandem duplications on Indian acute promyelocytic leukemia patients: Prognostic implications. Hematology 12 (2):99-101. 2007

BOOKS PUBLISHED


# Title Publication Year

BOOK CHAPTERS PUBLISHED


# Chapter Title Book Title Publication Year

ACADEMIC PROFILE


# Examination Passing Year Country
1. MBA in Hospital Administration (MBA-HA) 2020 India
2. Ph.D. 2012 India
3. M.Sc. (Biochemistry) 2003 India

EMPLOYMENT DETAILS


# Institution Position Country Service Period
1. All India Institute of Medical Sciences, New Delhi Research Scholar India 14 years, 0 months, 27 days
2. CSJM PG India 9 years, 11 months, 23 days
3. CSJM UG India 0 years, 11 months, 27 days
Total Period : 25 years, 0 months, 17 days

PAPERS PRESENTED IN CONFERENCES



RESEARCH PROJECTS



MEMBERSHIPS



TRAINING PROGRAMS ATTENDED



HONOURS AWARDS AND DISTINCTIONS



EVENTS ATTENDED



EVENTS ORGANIZED